2003
DOI: 10.1530/eje.0.1490239
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of stress-activated protein kinase/c-Jun N-terminal kinase in endothelin-1-induced heat shock protein 27 in osteoblasts

Abstract: Objective: We have reported that endothelin-1 (ET-1) activates p38 mitogen-activated protein (MAP) kinase through protein kinase C in osteoblast-like MC3T3-E1 cells, and that p38 MAP kinase plays a role in the ET-1-induced heat shock protein 27 (HSP27). Recently, we found that stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) is activated by ET-1 in these cells. In the present study, we have investigated the involvement of SAPK/JNK in ET-1-induced HSP27 in MC3T3-E1 cells. Methods: The concentr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

2004
2004
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 28 publications
0
9
0
Order By: Relevance
“…The compounds PD98059 (ERK inhibitor; Maiti et al, 2008), SB203580 (p38 inhibitor; Maiti et al, 2008), and SP600125 (JNK Inhibitor – SP600125; Tokuda et al, 2003) were obtained from Cell Signaling Technologies (Hertfordshire, UK) and used in the concentration range of 3–30 μM as based on published data (Gallicchio et al, 2009). In selected experiments the ERK inhibitor (10 μM) was tested against peptide Ac2-26 validating blockade of phosphor-ERK accumulation by Western blotting using a described methodology (Hayhoe et al, 2006).…”
Section: Methodsmentioning
confidence: 99%
“…The compounds PD98059 (ERK inhibitor; Maiti et al, 2008), SB203580 (p38 inhibitor; Maiti et al, 2008), and SP600125 (JNK Inhibitor – SP600125; Tokuda et al, 2003) were obtained from Cell Signaling Technologies (Hertfordshire, UK) and used in the concentration range of 3–30 μM as based on published data (Gallicchio et al, 2009). In selected experiments the ERK inhibitor (10 μM) was tested against peptide Ac2-26 validating blockade of phosphor-ERK accumulation by Western blotting using a described methodology (Hayhoe et al, 2006).…”
Section: Methodsmentioning
confidence: 99%
“…Protein samples were mixed with an equal volume of 2Â SDS sample buffer, boiled for 10 min, and subjected to 8% SDS-PAGE and Western blot analysis as described previously [Tokuda et al, 2003]. The nitrocellulose membrane was blocked with 5% milk, Tris-buffered saline (TBS)-0.2% Tween-20 (TTBS) for 2 h, and incubated with primary antibody (0.5 mg/ml) for 2 h. The blot was then washed three-times in TTBS and incubated with 0.1 mg/ml of HRPconjugated goat anti-rabbit IgG secondary antibody (Pierce) for 2 h at room temperature.…”
Section: Western Blot Analysismentioning
confidence: 99%
“…HSPs are multifunctional proteins involved in a variety of cellular activities such as antiapoptotic self-protection in response to cytotoxic environments Cooper et al 2000), tissue regeneration (Hebb et al 2006;Laplante et al 1998), actin stabilization (Russotti et al 1997), and differentiation by regulating caspase activity and stabilizing proteins associated with differentiation (Lanneau et al 2007). In particular, HSP27 is involved in bone physiology through upregulation of TGF-β (Hatakeyama et al 2002) and estrogen (Cooper and Uoshima 1994) which can increase bone mass, endothelin-1 (Tokuda et al 2003), and prostaglandins (Kozawa et al 2001). HSP47 is a procollagen-binding protein expressed in the endoplasmic reticulum (Nagata 1998) and involved in the biosynthesis of type I collagen (Dafforn et al 2001), a major bone extracellular matrix protein.…”
Section: Introductionmentioning
confidence: 99%